Announced Fri, 11 Sept, 2026 · 15:03 IST
Bafna Pharma 31st AGM held; 3 ordinary resolutions transacted
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹307.60
prior close
₹301.45
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
——+0.0—-0.1+0.2+0.8+3.1+5.2+9.4+27.8———
Up moveDown movePending
AI summary
Bafna Pharmaceuticals held its 31st AGM on September 11, 2026 via video conferencing from 10:00 AM to 10:35 AM. Three ordinary resolutions were transacted: adoption of audited financial statements for FY ended March 31, 2026; re-appointment of Mr. Upendar Mekala Reddy as Director (retires by rotation); and ratification of remuneration to Cost Auditors for FY 2026-2027. Remote e-voting was open from September 8 to 10, 2026, and voting results will be declared within two working days.
Likely market impact
Routine procedural filing; no material business changes. Voting results expected within two working days.